Acadia Pharmaceuticals Inc SEC filings ACAD
Acadia Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Nov 9, 2010. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 24, 2026 | May 29, 2026 |
| DEF 14A | Proxy statement | Apr 25, 2025 | May 29, 2025 |
| DEF 14A | Proxy statement | Apr 26, 2024 | May 29, 2024 |
| DEF 14A | Proxy statement | May 1, 2023 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 7, 2022 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 22, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 23, 2020 |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 26, 2019 |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 6, 2018 |
| DEFA14A | Additional proxy material | Apr 27, 2017 | — |
| DEF 14A | Proxy statement | Apr 27, 2017 | Jun 13, 2017 |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jun 10, 2016 |
| DEFA14A | Additional proxy material | Apr 29, 2015 | — |
| DEF 14A | Proxy statement | Apr 29, 2015 | Jun 15, 2015 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2015 | Jun 15, 2015 |
| DEFA14A | Additional proxy material | Apr 23, 2014 | — |
| DEF 14A | Proxy statement | Apr 23, 2014 | Jun 6, 2014 |
| DEF 14A | Proxy statement | Apr 25, 2013 | Jun 7, 2013 |
| DEF 14A | Proxy statement | Apr 18, 2012 | Jun 8, 2012 |
| DEFA14A | Additional proxy material | Apr 26, 2011 | — |
| DEF 14A | Proxy statement | Apr 25, 2011 | Jun 10, 2011 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2011 | Jun 10, 2011 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACAD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1070494
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.